Vimarsana
Biggest News Aggregation in the World

Page 3 - Featured Article News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Featured Article. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Featured Article Today - Breaking & Trending Today

Amazon unveils Featured Articles feature in India: Here's how it works | Technology News - Vimarsana News

Amazon unveils Featured Articles feature in India: Here's how it works | Technology News

Highlights The ecommerce platform is said to have launched a ‘Featured Articles’ feature on Android and iOS which is hidden in the Kindle section and it provides users access to featured articles, commentary, and opinions on a variety of topics. Some of the articles are exclusively available on Amazon India’s website and that the company is also sending notifications to some Kindle users to inform them. Amazon has unveiled a new feature on its platform in India without making much noise about it. It is aimed at helping users to spend more time on its platform.  The ecommerce platform i...

Source: india.com
Potential treatment of breast cancer through targeted drugs, reveals new study - Vimarsana News

Potential treatment of breast cancer through targeted drugs, reveals new study

Washington [US], May 2 (ANI): A team of researchers has discovered strong evidence that prolactin, a hormone responsible for breast growth and production of milk during pregnancy acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease.

Source: aninews.in
Breakthrough study uncovers potential treatment of breast cancer through targeted drugs - Vimarsana News

Breakthrough study uncovers potential treatment of breast cancer through targeted drugs

Breakthrough study uncovers potential treatment of breast cancer through targeted drugs Breakthrough study uncovers potential treatment of breast cancer through targeted drugs Last Updated: Tue, Apr 27th, 2021, 10:20:08hrs Washington [US], April 27 (ANI): A recent study led by researchers at the Virginia Commonwealth University (VCU) Massey Cancer Center found strong evidence that prolactin, a hormone responsible for breast growth and production of milk during pregnancy acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to...

Source: sify.com
Studies connect hormone to breast cancer and uncover potential for novel targeted drugs - Vimarsana News

Studies connect hormone to breast cancer and uncover potential for novel targeted drugs

Credit: VCU Massey Cancer Center The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey Cancer Center finds strong evidence that prolactin also acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease. Hormones have proteins on their cell surface called receptors that receive and send biological messages and regulate cell function. Through research ...

Featured Article: Using every tool in the box to combat honey fraud - Vimarsana News

Featured Article: Using every tool in the box to combat honey fraud

Featured Article: Using every tool in the box to combat honey fraud 18 Adulterated honey is a major threat to the industry, which is why companies like Intertek are employing powerful testing capabilities to detect chemical modifications to combat honey launderers. Honey has always been big business, but in recent years, demand for the product has seen a major increase. The size of the global market for this natural, energy-rich sweetener grew to $9.79 billion in 2019, and is expected to reach $14.43 billion by 2025. However, the increasing popularity of honey only serves to further incentivi...